chr11-47332891-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 3P and 16B. PM5PP3BP4_StrongBP6_Very_StrongBS2

The NM_000256.3(MYBPC3):​c.3413G>A​(p.Arg1138His) variant causes a missense change. The variant allele was found at a frequency of 0.000529 in 1,608,202 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1138C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00048 ( 4 hom. )

Consequence

MYBPC3
NM_000256.3 missense

Scores

13
3
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:2B:13

Conservation

PhyloP100: 5.82
Variant links:
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-47332891-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 42712.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=6, Likely_pathogenic=3}.
PP3
Multiple lines of computational evidence support a deleterious effect 9: BayesDel_addAF, BayesDel_noAF, Cadd, Dann, Eigen, MutationAssessor, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.019530088).
BP6
Variant 11-47332891-C-T is Benign according to our data. Variant chr11-47332891-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 177689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-47332891-C-T is described in Lovd as [Likely_benign]. Variant chr11-47332891-C-T is described in Lovd as [Pathogenic].
BS2
High Homozygotes in GnomAdExome4 at 4 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYBPC3NM_000256.3 linkc.3413G>A p.Arg1138His missense_variant Exon 31 of 35 ENST00000545968.6 NP_000247.2 Q14896-1A5YM48

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYBPC3ENST00000545968.6 linkc.3413G>A p.Arg1138His missense_variant Exon 31 of 35 5 NM_000256.3 ENSP00000442795.1 Q14896-1
MYBPC3ENST00000399249.6 linkc.3413G>A p.Arg1138His missense_variant Exon 30 of 34 5 ENSP00000382193.2 A8MXZ9

Frequencies

GnomAD3 genomes
AF:
0.000993
AC:
151
AN:
152134
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0123
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00113
AC:
267
AN:
237226
AF XY:
0.00109
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000302
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000575
Gnomad FIN exome
AF:
0.0111
Gnomad NFE exome
AF:
0.000298
Gnomad OTH exome
AF:
0.000346
GnomAD4 exome
AF:
0.000481
AC:
700
AN:
1455950
Hom.:
4
Cov.:
35
AF XY:
0.000489
AC XY:
354
AN XY:
723628
show subpopulations
Gnomad4 AFR exome
AF:
0.00
AC:
0
AN:
33402
Gnomad4 AMR exome
AF:
0.0000457
AC:
2
AN:
43746
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
25960
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39526
Gnomad4 SAS exome
AF:
0.00
AC:
0
AN:
84884
Gnomad4 FIN exome
AF:
0.0105
AC:
556
AN:
52882
Gnomad4 NFE exome
AF:
0.0000973
AC:
108
AN:
1109614
Gnomad4 Remaining exome
AF:
0.000565
AC:
34
AN:
60178
Heterozygous variant carriers
0
37
74
111
148
185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000992
AC:
151
AN:
152252
Hom.:
0
Cov.:
32
AF XY:
0.00154
AC XY:
115
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.0000963
AC:
0.0000963298
AN:
0.0000963298
Gnomad4 AMR
AF:
0.00
AC:
0
AN:
0
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.0123
AC:
0.0123259
AN:
0.0123259
Gnomad4 NFE
AF:
0.000221
AC:
0.000220562
AN:
0.000220562
Gnomad4 OTH
AF:
0.000474
AC:
0.000474383
AN:
0.000474383
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000121
Hom.:
0
Bravo
AF:
0.0000756
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.000951
AC:
115

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:2Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Aug 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26332594, 22763267, 19150014, 21310275, 12110947, 22765922, 20800588, 29032884, 31006259) -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiomyopathy Benign:3
Dec 06, 2017
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 13, 2018
Color Diagnostics, LLC DBA Color Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2023
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy Uncertain:1Benign:1
-
Zaffran Lab, Genetics of Cardiac Diseases Laboratory, Marseille Medical Genetics
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

Dec 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Feb 11, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

proposed classification - variant undergoing re-assessment, contact laboratory -

Primary dilated cardiomyopathy Benign:1
Mar 25, 2014
Blueprint Genetics
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy 4 Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary familial hypertrophic cardiomyopathy Benign:1
Mar 25, 2014
Blueprint Genetics
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 01, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Hypertrophic cardiomyopathy 1 Benign:1
Mar 18, 2015
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

The MYBPC3 Arg1138His variant has been previously reported in both the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/) at a frequency of 0.017 (72 of 4168 in the European Finnish population), and at a frequency of 0.002 in the European sub-population of the 1000 genomes project (http://www.1000genomes.org/). We observed this variant in a single proband with typical HCM, presented 27 years and has no clear family history of disease. No other variants were identified. The variant has been reported in the literature (Jääskeläinen P, et al., 2002; García-Castro M, et al., 2009; Golbus JR, et al., 2012). Jääskeläinen et al. (2002) sequenced MYBPC3 in a Finnish HCM population and normal cohort, and identified this Arg1138His variant in multiple families (3 unrelated probands and 5 normal control samples). The variant does not co-segregate with disease and homozygous individuals did not express the HCM phenotype. Another report from Garcia-Castro et al. (2009) identified the Arg1138His variant in a single proband amongst a Spanish HCM population, however this proband is described as having no family history of disease and a concentric pattern of hypertrophy (IVS and PW 19mm). Arginine (Arg) at position 1138 is conserved across distantly related species, however the computational tool specifically designed to predict the effects of missense variants in HCM genes (Jordan DM, et al., 2011), cannot predict the outcome of this MYBPC3 Arg1138His variant. Due to the allele frequency of > 0.001 in population databases, and literature evidence, we classify this variant as "likely benign". -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.54
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Pathogenic
0.44
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.54
D;T;T
Eigen
Pathogenic
0.97
Eigen_PC
Pathogenic
0.85
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Pathogenic
1.0
D;D;D
MetaRNN
Benign
0.020
T;T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.9
H;.;.
PrimateAI
Uncertain
0.54
T
PROVEAN
Pathogenic
-4.6
D;.;D
REVEL
Pathogenic
0.91
Sift
Pathogenic
0.0
D;.;D
Sift4G
Pathogenic
0.0010
D;D;D
Vest4
0.97
MVP
0.95
MPC
0.93
ClinPred
0.31
T
GERP RS
5.4
Varity_R
0.68
gMVP
0.86
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs187705120; hg19: chr11-47354442; COSMIC: COSV57033451; COSMIC: COSV57033451; API